Clinical Trial Update: Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver [Phase 1, Phase 2]

View source ↗

Summary

This update reports on the safety and efficacy outcomes from a Phase 1/Phase 2 trial of NV1020 in colorectal cancer that has metastasized to the liver.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Neoplasms

Drugs mentioned

• NV1020

Snippet

Sponsor: MediGene | Conditions: Colorectal Cancer, Liver Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-04-24